Dementia

More than one in 10 adults in the UK (14%) believe their brain health has declined since the start of the COVID-19 pandemic, new polling by Alzheimer’s Research UK

Researchers in Sweden found levels of certain blood-based proteins predicted worsening memory and thinking in a group of people with mild cognitive impairment (MCI).

‘Only together,’ the charity’s first-ever influencing campaign, highlights the low level of specialist support currently available to families affected by dementia, and how access to quality care could be improved.  

Top clinicians and dementia experts from the NHS, universities, pharmaceutical organisations and charities have today (Tuesday 17 November) published their consensus on Mild Cognitive Impairment (MCI).

Housing association The Guinness Partnership has championed unique ‘Bring Dementia Out’ training for employers in the housing and care sectors. Guinness staff

Dementia care provider, Belong, has recognised the outstanding achievements of its colleagues in a jubilant celebration at its annual Champion Awards.

A study led by researchers from Queen’s University Belfast has found anticholinergic drugs significantly increase the risk of mortality in people with dementia.

Dementia is having a crippling effect on the NHS and government must act now, says Alzheimer’s Research UK, as the charity reveals the cost of the condition on hospitals

More people are dying at home from dementia than ever before, as new figures reveal a shocking 79% increase in deaths compared to previous years.

New research published in the scientific journal Lancet Psychiatry reports that over half of those who contracted COVID-19 on mental health wards also had dementia.

Measures introduced to protect older people from COVID-19 may be as detrimental as the virus itself, according to local charitable organisation Belong.

From Bananarama Bread to Bread Sheeran and The Rolling Scones, musical baking puns are on the menu in October as Playlist for Life launches a nationwide fundraising campaign

New research published in the journal Diabetes Care suggests that the drug metformin may help reduce a decline in memory and thinking skills in people with diabetes